Transcriptic

What Transcriptic does

Strateos, Inc. (formerly Transcriptic) operates what it describes as the world's first R&D Cloud Automation Platform for life sciences, providing cloud-connected robotic laboratories accessible to scientists via a web browser. Founded in 2016 as Transcriptic, the company merged with 3Scan in 2019 and rebranded to Strateos, combining robotic cloud lab capabilities with tissue imaging technology. The platform offers three primary service tiers: remote access to Strateos-operated cloud labs (Control Our Lab), software for customers to control their own instruments (Control Your Lab), and lab design-build services (Build Your Lab), supported by additional solutions in AI for Drug Discovery, Antibody Discovery, Discovery Biology, Small Molecule Drug Discovery, Chemistry, Synthetic Biology, Tissue Technology, and High Content Imaging.

The platform integrates high-throughput lab automation with cloud-connected robotics, an in-house lab control software stack, and the Autoprotocol open-source experiment-description standard. Core technical components include the browser-based experiment design interface, a login portal at secure.strateos.com, and a developer portal at developers.strateos.com. The company operates two physical lab facilities in San Diego and Menlo Park and serves pharmaceutical companies, biotechnology firms (from early-stage startups to established players), contract research organizations, academic institutions, and AI-driven drug discovery companies.

Strateos generates revenue through subscription-based access to its cloud lab platform, software licensing for its lab control software, and professional services for lab design and build projects. Go-to-market combines enterprise field sales targeting pharma and biotech accounts, event-driven demand generation (including its own annual Cloud Lab, HTE, & Lab Automation Virtual Conference), and product-led growth through self-service web-based experiment access. Pricing is quote-based with no publicly disclosed tiers. As of March 2021, the company had raised $56 million in Series B funding.

Name

Transcriptic

Legal name

Strateos, Inc.

Website

https://transcriptic.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform that lets pharmaceutical, biotechnology, academic, and AI drug discovery customers design, run, and analyze life sciences experiments remotely on cloud-connected robotic laboratories via web browser.

Ownership category

akta.pro rank

Product category

Cloud Lab Automation Platform

NAICS

Software Publishers (513210), Computer Systems Design and Related Services (5415), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Lab Automation, Instrument Control & Workflow Orchestration Software (HLAGAJAG)

akta.pro secondary industries

Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), iBPMS (Intelligent BPM Suites) & Process Automation Suites (HDAEAHAG)

Keywords

• Cloud lab automation
• Drug discovery services
• Lab robotics
• High-throughput experimentation
• Life sciences R&D

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Infrastructure, Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Cloud Lab Automation-as-a-Service: Subscription-based access to remote-controlled robotic laboratories. Scientists access the cloud lab via web browser to run experiments. Model combines recurring subscription elements with usage-based components based on experiment volume and complexity.
2. Lab Build Services: Smart lab facility design-build services and lab control software implementation for organizations wanting to control their own facilities. One-time professional services and implementation revenue.
3. Software Licensing: Lab control software deployed to customer facilities for remote instrument control, workflow scheduling, and data management.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform that lets scientists design, run, and analyze life sciences experiments remotely through a web browser by combining cloud-connected robotic laboratory equipment with intelligent lab control software and high-throughput experimentation. The company also provides Lab Build design-build services and on-premises Lab Control Software for organizations wanting to operate their own cloud-connected robotic facilities, alongside specialized drug discovery, synthetic biology, chemistry, and imaging solutions.

Product overview

Strateos (formerly Transcriptic) operates a Cloud Lab Automation-as-a-Service Platform as its core offering, reimagining the laboratory as a smart data generation center. The platform provides three primary service tiers: 'Control Our Lab' for accessing Strateos-operated remote automated cloud laboratories via web browser, 'Control Your Lab' for organizations to control their own scientific instruments and facilities using design-build services and lab control software, and 'Build Your Lab' for smart lab facility construction. Specialized drug discovery solutions include AI for Drug Discovery, Antibody Discovery, Discovery Biology, Small Molecule Drug Discovery (with sub-services for assay development, automation, chemical libraries, hit identification, and lead optimization), Chemistry, Synthetic Biology, Tissue Technology, and High Content Imaging. Additional capabilities include Auto-DMTA for automated design-make-test-analyze loops and Virtual Tour access to facilities in San Diego and Menlo Park.

Differentiator

Problem solved

Functional benefit

Products and services

• Strateos Cloud Lab (Cloud Lab Automation-as-a-Service Platform)
• Control Your Lab
• Build Your Lab
• AI for Drug Discovery
• Antibody Discovery
• Discovery Biology
• Small Molecule Drug Discovery
• Chemistry (Medicinal Chemistry)

Quantifiable outcome

• Significant decrease in hands-on scientist time through automated experiment execution
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Strateos Small Molecule Discovery PartnershipcoreStrategic or Co-development Partner · 7 April 2022Launch of Rapid Idea-to-Data Solution for Small Molecule Discovery on Strateos' Cloud Lab Automation-as-a-Service Platform, enabling accelerated drug discovery workflows from hit identification through lead optimization.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• Emerald Cloud Lab: Emerald Cloud Lab operates a remote-controlled, cloud-accessible life sciences laboratory similar to Strateos, allowing scientists to run experiments via web browser. It is the closest direct competitor in the cloud lab automation-as-a-service category.
• Arctoris: Arctoris offers a fully automated, cloud-operated drug discovery platform combining robotics with AI-driven experiment design. It directly overlaps Strateos's cloud lab automation model for small molecule discovery.
• HighRes Biosolutions: HighRes Biosolutions provides integrated lab automation robotics and scheduling software for life sciences, used by pharma and biotech to build their own automated facilities. It is the primary alternative for customers choosing 'Build Your Lab' or 'Control Your Lab' over Strateos's cloud lab.

Broad incumbents

• Benchling: Benchling provides a cloud-based R&D platform spanning ELN, LIMS, and molecular biology workflows used by major pharma and biotech. It competes with Strateos's lab control software layer for informatics ownership, though Benchling does not operate physical robotic labs.
• Dotmatics: Dotmatics is an established scientific informatics platform (ELN, LIMS, data analysis) used broadly across pharma R&D. It overlaps with Strateos's lab control software and data management offerings as part of a wider portfolio rather than a specialized cloud lab.
• LabVantage Solutions: LabVantage is an established LIMS provider used in regulated pharmaceutical and biotech QC/research labs. It competes with Strateos's compliance and lab data management capabilities as a broad incumbent.

Emerging players

• Ginkgo Bioworks: Ginkgo operates a large-scale synthetic biology platform with significant automation and is a customer and partner-class comparable in lab automation-as-a-service for synbio. Overlap is partial: Ginkgo's automation is internal and serves its own programs, but the technology stack and target customers overlap with Strateos's synthetic biology offering.
• TetraScience: TetraScience provides a scientific data cloud and integration platform for R&D labs, ingesting instrument data from life sciences labs. It competes with Strateos's scientific data management and lab control software components, though without owning physical lab infrastructure.
• Scitara: Scitara provides a Scientific Integration Platform (iPaaS) for connecting lab instruments and informatics systems. It overlaps with Strateos's lab control and instrument integration capabilities at the software layer.
• Recursion Pharmaceuticals: Recursion operates an AI-driven drug discovery platform combining high-throughput wet-lab experimentation with machine learning. Its automation philosophy and target customers (AI pharma, biotech) overlap with Strateos's AI for Drug Discovery positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• GitHubgithub.com/strateos/transcriptic
• Xx.com/transcriptic
• LinkedInlinkedin.com/company/transcriptic

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Transcriptic